| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
CASI Pharmaceuticals, Inc.
13G/A
CASIF · G1933S101
|
13.8% |
7/23/2025
Event 6/30/2025
|
||||
| Panacea Venture Healthcare Fund II, L.P. | 13.2% | |||||
| Panacea Venture Healthcare Fund II GP Company, Ltd. | 13.2% | |||||
| Panacea Innovation Limited | 13.2% | |||||
| James Huang | 13.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.